Advanced Life Sciences Holdings
Business Services · 11-50 Employees
View Company Info for Free
Overview
Phone Number
(630) 739-6744Website
www.advancedlifesciences.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Advanced Life Sciences Holdings
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs in the therapeutic areas of infection, oncology, and respiratory disease. The companys lead product candidate includes Restanza, a once-a-day oral antibiotic for the treatment of respiratory tract infections, including community acquired bacterial pneumonia and biodefense pathogens, such as anthrax, plague, and tularemia. It is also developing ALS-357, a compound for the topical treatment of malignant melanoma; and ALS-886, a therapeutic for the treatment of inflammation-related tissue damage consisting of tissue damage associated with acute respiratory distress syndrome. The company has collaboration agreements with Abbott Laboratories to develop and commercialize cethromycin; University of Illinois to develop, make, use, and sell ALS-357 and related compounds; and Baxter International, Inc. Advanced Life Sciences Holdings, Inc. was founded in 1999Read more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Advanced Life Sciences Holdings your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Advanced Life Sciences Holdings has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Advanced Life Sciences Holdings
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Advanced Life Sciences Holdings has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Advanced Life Sciences Holdings launches new products
Advanced Life Sciences Holdings, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Advanced Life Sciences Holdings had a recent Job posting/layoffs
Check out if Advanced Life Sciences Holdings is spiking on competitors!
Earning: See what the market has to say on Advanced Life Sciences Holdings recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Advanced Life Sciences Holdings as Masked Content
Find more new buyers
Compare Similar Companies to Advanced Life Sciences Holdings
Compare insights from companies similar to Advanced Life Sciences Holdings, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Advanced Life Sciences Ho...
<$5M
11-50
Private
-
1999
N/A
<$5M
1-10
Private
$37.5M
2011
Company Profile Activity
Activity Insights
Advanced Life Sciences Holdings is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Advanced Life Sciences Holdings is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Advanced Life Sciences Holdings.
Advanced Life Sciences Holdings Tech Stack
A closer look at the technologies used by Advanced Life Sciences Holdings
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Advanced Life Sciences Holdings
Sign Up For FreeTo access detailed company insights
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs in the therapeutic areas of infection, oncology, and respiratory disease. The companys lead product candidate includes Restanza, a once-a-day oral antibiotic for the treatment of respiratory tract infections, inc... Read More
